Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / XBI - Despite Market Reaction Aurinia Pharmaceuticals Is On Track And Ahead Of Schedule

XBI - Despite Market Reaction Aurinia Pharmaceuticals Is On Track And Ahead Of Schedule

SPDR Series Trust S&P Biotech
  • Aurinia Pharmaceuticals, along with biotechs in general, has been beaten down recently.
  • I explore the reasons specific to Aurinia and then compare recent results to my valuation model.
  • My model turns out to be very conservative and it still arrives at a target price of $75 for AUPH stock (with a 5 year range).
  • As such, I continue to accumulate AUPH shares at today's prices.

For further details see:

Despite Market Reaction, Aurinia Pharmaceuticals Is On Track And Ahead Of Schedule
Stock Information
Company Name: SPDR Series Trust S&P Biotech
Stock Symbol: XBI
Market: NYSE
Menu
XBI XBI Quote XBI Short XBI News XBI Articles XBI Message Board
Get XBI Alerts

News, Short Squeeze, Breakout and More Instantly...